CLINICAL_TRIALS
trial_result
· 2013-02-11
Clinical Trial Update: Suboptimal Responders to Adefovir Switching to Entecavir [Phase 4]
Summary
Phase 4 trial update on chronic hepatitis B patients who were suboptimal responders to adefovir and switched to entecavir; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2013-02-11